Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
Jacobs
Michael R
MR
Department of Pathology, University Hospitals Case Medical Center/CWRU, Cleveland, OH 44106, USA. mrj6@cwru.edu
Good
Caryn E
CE
Windau
Anne R
AR
Bajaksouzian
Saralee
S
Biek
Donald
D
Critchley
Ian A
IA
Sader
Helio S
HS
Jones
Ronald N
RN
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002511:Cephalosporins / Q000494:pharmacology*; D021821:Communicable Diseases, Emerging / Q000188:drug therapy / Q000382:microbiology; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans; D066298:In Vitro Techniques; D008826:Microbial Sensitivity Tests; D011008:Pneumococcal Infections / Q000188:drug therapy* / Q000382:microbiology*; D012703:Serotyping; D013296:Streptococcus pneumoniae / Q000145:classification* / Q000187:drug effects* / Q000302:isolation & purification; D014481:United States; D000097583:Ceftaroline
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D000097583:Ceftaroline